In this landscape, cytotoxic lymphocytes—including CD8+ CTLs, NK, and γδ T cells—play pivotal roles in anti-tumor immunity, although challenges in defining biomarkers and reversing their exhaustion remain 22, 23. Here, CD8A is linked to neoplasm.